I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review

I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review

Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, which have abnormal aggregations of α-synuclein in the nigral and extranigral areas, including in the heart. 123I-metaiodobenzylguanidine (MIBG) scintigraphy is a well-known tool to evaluate cardiac sympa...

Full description

Bibliographic Details
Main Authors:	Eun Joo Chung, Sang Jin Kim
Format:	Article
Language:	English
Published:	Korean Movement Disorders Society 2015-05-01
Series:	Journal of Movement Disorders
Subjects:	I-metaiodobenzylguanidine scintigraphy Lewy body-related disorders Parkinsonism Dementia
Online Access:	http://e-jmd.org/upload/jmd-8-2-55.pdf

Similar Items

Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
by: Yoshito Kamiya, et al.
Published: (2017-01-01)

Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01)

Cardiac I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Gene Mutation
by: Young-Do Kim, et al.
Published: (2010-10-01)

Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer's Disease
by: Toshiya Fukui, et al.
Published: (2013-05-01)

The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01)

Lewy Body Dementias: A Coin with Two Sides?
by: Ángela Milán-Tomás, et al.
Published: (2021-06-01)

Clinicopathological Correlates of Lewy Body Disease: Fundamental Issues
by: Tae-Beom Ahn
Published: (2010-05-01)

Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01)

Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings
by: Bethany Peterson, et al.
Published: (2019-03-01)

Lewy body constipation
by: Ryuji Sakakibara, et al.
Published: (2019-01-01)

Clinical characteristics of Lewy body dementia in Chinese memory clinics
by: Jinghuan Gan, et al.
Published: (2021-03-01)

Clinical prevalence of Lewy body dementia
by: Joseph P. M. Kane, et al.
Published: (2018-02-01)

Navigating Unchartered Waters: A Nursing Perspective on Lewy Body Dementia
Published: (2018-06-01)

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
by: Masahito Yamada, et al.
Published: (2020-01-01)

Metaiodobenzylguanidine in the assessment of the ends of myocardial sympathetic fibers in patients with bronchial asthma
by: S A Boitsov, et al.
Published: (2003-03-01)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
by: Georgina M. Aldridge, et al.
Published: (2018-03-01)

Diagnostic Accuracy of Apparent Diffusion Coefficient and 123I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson's Disease
by: Umemura, Atsushi
Published: (2015)

Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review
by: Stefania Pezzoli, et al.
Published: (2017-07-01)

The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies—A Systematic Review
by: Zhe Kang Law, et al.
Published: (2020-08-01)

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
by: Arnab Datta, et al.
Published: (2017-08-01)

The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data
by: Tousi B, et al.
Published: (2021-05-01)

Young-Onset Dementia with Lewy Bodies
by: Yosuke Aiba, et al.
Published: (2018-12-01)

Dementia with Lewy bodies and Parkinson’s disease dementia-two independent disorders or one clinical entity within a clinical spectrum of synucleinopathies?
by: Papuć Ewa
Published: (2020-09-01)

A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease
by: Benjamin R. Smith, et al.
Published: (2019-07-01)

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases
by: Walter Maetzler, et al.
Published: (2009-08-01)

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report
by: Teruaki Sugino, et al.
Published: (2017-12-01)

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial
by: Greg J. Elder, et al.
Published: (2019-01-01)

Topography of cortical thinning in the Lewy body diseases
by: Rong Ye, et al.
Published: (2020-01-01)

The thinking on controversy of "1-year rule" for differential diagnosis between Parkinson's disease dementia and dementia with Lewy bodies
by: Shu-hua LI, et al.
Published: (2017-01-01)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
by: Mariya Petrova, et al.
Published: (2015-05-01)

Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy
by: Aintzane Urbizu, et al.
Published: (2020-07-01)

Diagnosing dementia with Lewy bodies: new diagnostic criteria
by: S Liyanagedera, et al.
Published: (2018-03-01)

Parkin and synphilin-1 isoform expression changes in Lewy body diseases
by: Jordi Humbert, et al.
Published: (2007-06-01)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice
by: Cornelia Skowronek, et al.
Published: (2019-02-01)

Dosimetry estimation of SPECT/CT for iodine 123-labeled metaiodobenzylguanidine in children
by: Aida Mhiri, et al.
Published: (2015-09-01)

Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study
by: A. Mouton, et al.
Published: (2018-09-01)

Massive pheochromocytoma
by: Terumitsu Anai, et al.
Published: (2020-11-01)

Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders
by: Alan Robert Bowman, et al.
Published: (2017-05-01)

Demencia con cuerpos de Lewy: Presentación de 1 caso Dementia with lewy bodies: A case report
by: David Cubero Rego, et al.
Published: (2004-12-01)

Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies
by: Marta Barrachina, et al.
Published: (2006-05-01)